Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the European Commission (EC) has granted conditional marketing authorization for seladelpar for the treatment of primary biliary cholangitis ...

With the goal of informing clinician practice, a new study explores the harms and benefits of continuing and of discontinuing the long-term prescription of opioid medicines to adults with chronic pain ...

Chronic pain is complex and difficult to treat. Prescribing opioid pain medications has become controversial but may help ...

Changes like fibrosis, or scarring of the tissue in the liver, may lead to cirrhosis ... as this helps determine necessary treatment and hopefully prevent recurrent issues.” ...

Other forms of infection, such as fungal infections due to ringworm or yeast, may also cause similar pain and irritation in the area. Mild skin infections should clear up without treatment if a ...

Follow-up of patients is life-long and must address treatment of the disease and management of associated symptoms. autoimmune liver disease care pathway guidelines ... abdominal discomfort and ...

Chief Medical Officer at Central DuPage Hospital Dr. Tom Moran joins Bob Sirott to talk about prostate cancer awareness and the FDA’s approval of a new pain medication. He also explains a study that ...

(CNN) — The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than two decades. The drug, suzetrigine, is a 50-milligram ...

The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.

Tens of millions of Americans are prescribed opioids like hydrocodone, oxycodone and fentanyl each year for pain. Rising FDA approves new type of non-opioid pain medication ...

(NEW YORK) — The U.S. Food and Drug Administration (FDA) on Thursday approved a new type of prescription pain medication for adults to treat moderate to severe acute pain. The drug, called ...